Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis. | Sci Rep | 2023 | 37898694 | PubTator, text mining | PubMed |
| Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37894393 | PubTator, text mining | PubMed |
| Comprehensive Systematic Review of Biomarkers in Metastatic Renal Cell Carcinoma: Predictors, Prognostics, and Therapeutic Monitoring. | Cancers (Basel) | 2023 | 37894301 | PubTator, text mining | PubMed |
| An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer. | Res Sq | 2023 | 37886475 | PubTator, text mining | PubMed |
| A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's Disease. | bioRxiv | 2023 | 37873404 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Provides Insight into Skeletal Muscle Evolution during the Selection of Muscle Characteristics. | Adv Sci (Weinh) | 2023 | 37870215 | PubTator, text mining | PubMed |
| High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival. | NPJ Precis Oncol | 2023 | 37857854 | PubTator, text mining | PubMed |
| Correlation Analysis of Prognostic Gene Expression, Tumor Microenvironment, and Tumor-Infiltrating Immune Cells in Ovarian Cancer. | Dis Markers | 2023 | 37841886 | PubTator, text mining | PubMed |
| A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma. | Cancers (Basel) | 2023 | 37835538 | PubTator, text mining | PubMed |
| LILRB3 suppresses immunity in glioma and is associated with poor prognosis. | Clin Transl Med | 2023 | 37830127 | PubTator, text mining | PubMed |
| Analysis of potential biomarkers for diabetic kidney disease based on single-cell RNA-sequencing integrated with a single-cell sequencing assay for transposase-accessible chromatin. | Aging (Albany NY) | 2023 | 37827693 | PubTator, text mining | PubMed |
| Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells. | Mol Ther Methods Clin Dev | 2023 | 37822720 | PubTator, text mining | PubMed |
| PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages. | Cancer Res Commun | 2023 | 37819238 | PubTator, text mining | PubMed |
| Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters. | J Clin Invest | 2023 | 37815865 | PubTator, text mining | PubMed |
| Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. | Clin Transl Med | 2023 | 37784253 | PubTator, text mining | PubMed |
| High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma. | Front Immunol | 2023 | 37781365 | PubTator, text mining | PubMed |
| Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms. | Front Oncol | 2023 | 37781191 | PubTator, text mining | PubMed |
| High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC. | Sci Rep | 2023 | 37777573 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Investigating the Heterogeneity of Immune Cells in Triple-Negative Breast Cancer at the Single-Cell Level before and after Paclitaxel Chemotherapy. | Int J Mol Sci | 2023 | 37762493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=9